Skip to main content

Table 2 SIRs and HRs for myeloma after a specified AI disease by age at cancer diagnosis

From: Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma

  

0<Age<60

Age60

Autoimmune disease

Pyrs

O

SIR

95%CI

Deaths

HR

95%CI

O

SIR

95%CI

Deaths

HR

95%CI

Ankylosing spondylitis

112824

8

3.31

1.41-6.55

3

1.00

0.32-3.11

8

1.45

0.62-2.87

1

0.29

0.04-2.01

Behcet disease

63182

2

1.99

0.19-7.32

0

  

4

1.31

0.34-3.38

3

1.05

0.34-3.24

Chronic rheumatic heart disease

166242

6

2.79

1.00-6.11

4

1.25

0.47-3.33

17

0.75

0.43-1.20

5

0.82

0.34-1.96

Crohn disease

392264

5

0.89

0.28-2.09

3

1.47

0.47-4.57

10

0.79

0.38-1.46

6

1.12

0.50-2.50

Graves/hyperthyroidism

541104

7

0.98

0.39-2.04

5

2.48

1.03-5.98

45

1.04

0.76-1.39

24

0.80

0.53-1.19

Hashimoto/hypothyroidism

120705

1

0.85

0.00 -4.87

0

  

14

1.17

0.64-1.97

4

0.44

0.16-1.16

Immune thrombocytopenic purpura

44220

0

     

4

2.51

0.65-6.50

2

0.57

0.14-2.27

Multiple sclerosis

185014

3

0.86

0.16-2.56

0

  

10

1.04

0.49-1.92

8

1.84

0.92-3.68

Myasthenia gravis

32648

1

2.60

0.00-14.91

1

2.41

0.34-17.14

3

1.16

0.22-3.45

2

1.55

0.39-6.18

Pernicious anemia

67096

1

2.38

0.00-13.63

1

0.49

3.06-3.48

12

0.97

0.50-1.70

11

1.30

0.72-2.35

Polymyalgia rheumatica

253046

5

1.93

0.61-4.55

3

0.94

0.30-2.92

38

1.14

0.81-1.57

24

1.05

0.70-1.56

Polymyositis/dermatomyositis

24041

1

3.19

0.00-18.26

0

  

3

1.57

0.30-4.65

3

5.40

1.75-16.65

Psoriasis

27591

5

1.19

0.38-2.80

1

0.43

0.06-3.06

18

0.94-

0.55-1.48

10

0.80

0.43-1.49

Rheumatic fever

77388

1

0.76

0.00-4.35

1

21.17

2.96-151.59

7

1.50

0.60-3.11

5

4.60

1.91-11.06

Rheumatoid arthritis

731954

8

0.90

0.39-1.79

2

0.45

0.11-1.89

73

0.88

0.69-1.10

43

0.96

0.71-1.29

Sarcoidosis

177765

4

1.26

0.33-3.27

2

1.19

0.30-4.78

15

1.31

0.73-2.16

9

1.07

0.55-2.05

Sjögren syndrome

16700

1

4.58

0.00-26.27

0

  

3

1.78

0.33-5.26

1

0.34

0.05-2.38

Systemic lupus erythematosus

86627

6

5.19

1.87-11.36

3

1.42

0.46-4.41

5

0.95

0.30-2.23

2

0.86

0.22-3.45

Systemic sclerosis

89997

3

2.87

0.54-8.49

3

5.51

1.75-17.29

16

2.59

1.47-4.2

10

0.80

0.43-1.49

Ulcerative colitis

486704

11

1.50

0.75-2.70

6

0.85

0.38-1.89

27

1.31

0.86-1.90

15

1.05

0.63-1.74

Wegener granulomatosis

115746

2

3.91

0.37-14.36

2

1.91

0.48-7.68

24

1.11

0.71-1.65

14

0.71

0.42-1.20

All

4777665

84

1.45

1.16-1.80

40

0.96

0.70-1.32

373

1.07

0.96-1.18

211

0.92

0.80-1.06

  1. Bold type indicates that the 95% CI does not include 1.00.
  2. Abbreviations: Pyrs, person-years; O, observed; SIR, standardized incidence ratio; CI, confidence interval; HR, hazard ratio.